Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?
Feb 19 2020
•
By
Cathy Kelly
ICER Interested In More Engagement With FDA
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Market Access